T2 Biosystems Probability of Future Pink Sheet Price Finishing Under 0.5

TTOODelisted Stock  USD 0.18  0.05  21.74%   
T2 Biosystems' future price is the expected price of T2 Biosystems instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of T2 Biosystems performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
  
Please specify T2 Biosystems' target price for which you would like T2 Biosystems odds to be computed.

T2 Biosystems Target Price Odds to finish below 0.5

The tendency of TTOO Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 0.50  after 90 days
 0.18 90 days 0.50 
close to 99
Based on a normal probability distribution, the odds of T2 Biosystems to stay under $ 0.50  after 90 days from now is close to 99 (This T2 Biosystems probability density function shows the probability of TTOO Pink Sheet to fall within a particular range of prices over 90 days) . Probability of T2 Biosystems price to stay between its current price of $ 0.18  and $ 0.50  at the end of the 90-day period is about 77.99 .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 5.47 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, T2 Biosystems will likely underperform. Additionally T2 Biosystems has an alpha of 0.8754, implying that it can generate a 0.88 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   T2 Biosystems Price Density   
       Price  

Predictive Modules for T2 Biosystems

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as T2 Biosystems. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.1825.47
Details
Intrinsic
Valuation
LowRealHigh
0.010.1725.46
Details
Naive
Forecast
LowNextHigh
00.2525.53
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.070.180.30
Details

T2 Biosystems Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. T2 Biosystems is not an exception. The market had few large corrections towards the T2 Biosystems' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold T2 Biosystems, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of T2 Biosystems within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.88
β
Beta against Dow Jones5.47
σ
Overall volatility
0.10
Ir
Information ratio 0.02

T2 Biosystems Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of T2 Biosystems for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for T2 Biosystems can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
T2 Biosystems is not yet fully synchronised with the market data
T2 Biosystems had very high historical volatility over the last 90 days
T2 Biosystems has some characteristics of a very speculative penny stock
T2 Biosystems has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 7.19 M. Net Loss for the year was (50.08 M) with loss before overhead, payroll, taxes, and interest of (24.77 M).
T2 Biosystems currently holds about 13.21 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 74.0% of the company shares are owned by institutional investors

T2 Biosystems Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TTOO Pink Sheet often depends not only on the future outlook of the current and potential T2 Biosystems' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. T2 Biosystems' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.6 M
Cash And Short Term Investments15.7 M

T2 Biosystems Technical Analysis

T2 Biosystems' future price can be derived by breaking down and analyzing its technical indicators over time. TTOO Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of T2 Biosystems. In general, you should focus on analyzing TTOO Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

T2 Biosystems Predictive Forecast Models

T2 Biosystems' time-series forecasting models is one of many T2 Biosystems' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary T2 Biosystems' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about T2 Biosystems

Checking the ongoing alerts about T2 Biosystems for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for T2 Biosystems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
T2 Biosystems is not yet fully synchronised with the market data
T2 Biosystems had very high historical volatility over the last 90 days
T2 Biosystems has some characteristics of a very speculative penny stock
T2 Biosystems has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 7.19 M. Net Loss for the year was (50.08 M) with loss before overhead, payroll, taxes, and interest of (24.77 M).
T2 Biosystems currently holds about 13.21 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 74.0% of the company shares are owned by institutional investors
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in TTOO Pink Sheet

If you are still planning to invest in T2 Biosystems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystems' history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum